Sponsor Pipeline

Singapore National Eye Centre Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
13
Active Trials
6
Recruiting
2
Phase 3
Active Trials by Phase
Phase 3
2
Phase 2
2
Not specified
9
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT06863675 Highly Aspherical Lenslet (HAL) and Binocular Vision (BV) Disorders [HALT X(T) Study] Myopia Not Yet Recruiting
NCT03140358 The Use of Atropine 0.01% in the Prevention and Control of Myopia (ATOM3) Myopia Active, Not Recruiting
Phase 2
NCT06765603 Evaluating the Efficacy of the Combination of Multi-zonal Contact Lens and Atropine for… Myopia Not Yet Recruiting
NCT07681167 Faricimab for Chronic Central Serous Chorioretinopathy: A Randomized Sham-Controlled Trial Central Serous Chorioretinopathy (CSC) Not Yet Recruiting
Not specified
NCT07249216 Identification of Molecular Signals in Vitreous Humor Associated With Suboptimal Response… Age Related Macular Degeneration Recruiting
NCT07260097 Choroidal Venous Congestion Following Scleral Buckling - An Imaging Study Pachychoroid Disease Recruiting
NCT07329712 Comparing Tear Proteomics Profile in Dry Eye Disease pre-and Post-treatment With Low… Dry Eye Recruiting
NCT07554911 Detection and Optimization of Treatment of Severe Cases of Dry Eye Disease Dry Eye Recruiting
NCT07236671 Progression Patterns of Choroidal Venous Alterations Pachychoroid Disease Recruiting
NCT07653269 Predicting Risk of Progression of Early to Late AMD in the Aging Eye Through Imaging and… Age Related Macular Degeneration Recruiting
NCT06717035 Evaluation of Performance of MiYOSMART Photochromic and Clear Spectacle Lenses in Myopic… Myopia Not Yet Recruiting
NCT07176130 Demographics and Clinical Characteristics of Ocular Inflammatory Diseases in Singapore Uveitis Active, Not Recruiting
NCT07341724 Telemedicine for Evaluating Dry Eye Disease (DED) Using a Mobile Phone-Attached Portable… Dry Eye Not Yet Recruiting
Get alerts when Singapore National Eye Centre's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free